RARA and breast carcinoma: The antiproliferative, cytodifferentiating and proapoptotic effects of retinoids are predominantly mediated by the nuclear hormone retinoid acid receptors RARα, RARβ and RARγ.13, 14 In breast cancer, preclinical studies have shown that retinoids are promising therapeutic agents.